Kenneth T. Mills
President and CEO at REGENXBIO Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: REGENXBIO Inc., 3 years.
REGENXBIO Inc.
Director · President and CEO
Chief executive roles
REGENXBIO Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2026 | REGENXBIO Inc. | Grant or award | +9,807 | — | — |
| Jan 27, 2026 | REGENXBIO Inc. | Option exercise | +225,000 | $13.09 | $2,945,250 |
| Jan 27, 2026 | REGENXBIO Inc. | Shares withheld for tax | −221,753 | $13.41 | $2,973,708 |
| May 30, 2025 | REGENXBIO Inc. | Grant or award | +7,768 | — | — |
| May 12, 2025 | REGENXBIO Inc. | Option exercise | +20,602 | $3.76 | $77,464 |
| May 12, 2025 | REGENXBIO Inc. | Open-market sale | −20,602 | $7.91 | $162,962 |
| Mar 27, 2025 | REGENXBIO Inc. | Option exercise | +30,752 | $3.76 | $115,628 |
| Aug 8, 2024 | REGENXBIO Inc. | Option exercise | +36,316 | $0.85 | $30,869 |
| Jul 25, 2024 | REGENXBIO Inc. | Option exercise | +15,369 | $3.76 | $57,787 |
| Jul 25, 2024 | REGENXBIO Inc. | Open-market sale | −15,369 | $13.96 | $214,551 |
| Jul 24, 2024 | REGENXBIO Inc. | Option exercise | +12,221 | $3.76 | $45,951 |
| Jul 24, 2024 | REGENXBIO Inc. | Open-market sale | −12,221 | $13.78 | $168,405 |
| Jul 17, 2024 | REGENXBIO Inc. | Option exercise | +2,210 | $3.76 | $8,310 |
| Jul 17, 2024 | REGENXBIO Inc. | Open-market sale | −2,210 | $13.77 | $30,432 |
| Jul 16, 2024 | REGENXBIO Inc. | Option exercise | +200 | $3.76 | $752 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.